1.Department of Surgery, Mayo Clinic, Rochester, MN, USA ;2.Department of Health Science Research and Clinical Statistics, Mayo Clinic, Rochester, MN, USA ;3.Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA ;
Abstract:
Annals of Surgical Oncology - Tumor genomic prognostic assays estimate 10-year local recurrence risk in ductal carcinoma in situ (DCIS) and can guide treatment decisions. This study aimed to...